Genome Engineering
Aiming for More than Single-Base Corrections: The Technologies Opening the Genome to Therapeutic Cargo
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-26-PA-16Jun 29, 2026
Pathfinder
CRISPR vs. Base Editing vs. Prime Editing: Which Genome Editing Technology Is Best?
Nice Insight
PAO-26-PF-05May 1, 2026
Epigenome Editing
Rewriting Gene Expression Without Rewriting DNA: The Emerging Field of Epigenetic Editing
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-26-PA-12Apr 23, 2026
CVD Gene Editing
Editing Risk: Gene Targets for Lifelong Cardiovascular Disease Prevention
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-26-NI-07Feb 9, 2026
RNA Polymerase
Smarter Polymerases, Cleaner Transcripts, Better RNA
Jing Zhu, Ph.D.
Recipharm Advanced Bio
PAO-12-25-CL-04Dec 15, 2025
CRISPR
Integrated Capabilities Enable Faster Development of Effective CRISPR Therapies
Jessica Madigan; Amanda Haas
BIOVECTRA
PAO-11-25-CL-03Nov 21, 2025
Gene Editing
A Universal Strategy for Rare Diseases? Researchers Unveil a Mutation-Agnostic Editor
David Alvaro, Ph.D.
Pharma's Almanac
PAO-11-25-NI-07Nov 19, 2025
ssDNA
Leveraging the Therapeutic Potential of Single-Stranded DNA
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-07-25-NI-10Jul 23, 2025
Gene Editing
What are the key ethical and regulatory considerations as gene editing technologies advance toward widespread clinical use?
Pharma's Almanac
PAO-05-25-RT-02Jun 17, 2025
Xenotransplantation
CRISPR-Edited Pig Organs and the Promise of Xenotransplantation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-25-NI-13Apr 25, 2025
Gene Therapy
Gene Therapy at 30: Milestones, Setbacks, and a Path Forward
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-28Apr 14, 2025
RNA
Beyond mRNA Vaccines: The Expanding World of RNA-Based Therapeutics
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-24Mar 21, 2025
HTS
The High-Throughput Screening Transformation in Modern Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-12Mar 2, 2025
Small Biotechs
Five Small Biotechs to Watch: March 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-NI-06Feb 28, 2025
CASGEVY
Orsini Now Distributing CASGEVY® (exagamglogene autotemcel), a Gene-Editing Therapy
Orsini Healthcare
PR-11-24-NI-103Nov 15, 2024
CRISPR
The Groundbreaking Potential of CRISPR Gene Editing
Olivia Newton-John Cancer Research Institute
PAO-10-24-RTM-09Nov 5, 2024
Gene Editing
MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing
Tom Adie, Ph.D.; Elena Stoyanova, Ph.D.
Touchlight
PAO-10-24-CL-01Sep 30, 2024
dbDNA
Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA
Jill Makin
Touchlight
PAO-08-24-CL-01Aug 19, 2024
Cell Therapy
Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support
Sarah Meeks, Ph.D.
MaxCyte
PAO-09-23-CL-09Sep 28, 2023
Lipid Nanoparticle Development
Lipid Technology for Delivery of Gene-Editing Therapies
Stephen Burgess, Ph.D.
Croda Pharma
PAO-11-022-CL-18Jan 17, 2023